Seong-won Lee

Dr. Seong-won Lee


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2022 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
YOYoung Mi Oh
Young Mi Oh
SLSeong-won Lee
Seong-won Lee
WKWoo Kyung Kim
Woo Kyung Kim
SCShawei Chen
Shawei Chen
VCVictoria A. Church
Victoria A. Church
AYAndrew S. Yoo
Andrew S. Yoo

8 December 2023 in Nature Aging
Verified
Journal Article
Closed access
PDF file
SLSeong-won Lee
Seong-won Lee
YOYoung Mi Oh
Young Mi Oh
MVMatheus B. Victor
Matheus B. Victor
YYYan Yang
Yan Yang
SCShawei Chen
Shawei Chen
AYAndrew S. Yoo
Andrew S. Yoo

16 March 2024 in Molecules and Cells
Verified
Journal Article
Open access
YOYoung Mi Oh
Young Mi Oh
SLSeong-won Lee
Seong-won Lee
MicroRNAs play a crucial role in directly reprogramming (converting) human fibroblasts into neurons. Specifically, miR-9/9* and miR-124 (miR-9/9*-124) display neurogenic and cell fate-switching activities when ectopically expressed in human fibroblasts by erasing fibroblast identity and inducing a pan-neuronal state. These converted neurons maintain the biological age of the starting fibroblasts and thus provide a human neuron-based platform to study cellular properties in aged neurons and model adult-onset neurodegenerative disorders using patient-derived cells. Furthermore, the expression of striatal-enriched transcription factors in conjunction with miR-9/9*-124 guides the identity of medium spiny neurons (MSNs), the primary targets in Huntington's disease (HD). Converted MSNs from HD patient-derived fibroblasts (HD-MSNs) can replicate HD-related phenotypes including neurodegeneration associated with age-related declines in critical cellular functions such as autophagy. Here, we review the role of microRNAs in the direct conversion of patient-derived fibroblasts into MSNs and the practical application of converted HD-MSNs as a model for studying adult-onset neuropathology in HD. We provide valuable insights into age-related, cell-intrinsic changes contributing to neurodegeneration in HD-MSNs. Ultimately, we address a comprehensive understanding of the complex molecular landscape underlying HD pathology, offering potential avenues for therapeutic application.

4 September 2026 in Neuroscience Bulletin
Verified
Journal Article
Open access
PDF file
YOYoung Mi Oh
Young Mi Oh
EBEmily A. Bacallao
Emily A. Bacallao
SLShin-Ae Lee
Shin-Ae Lee
JKJihyun Kim
Jihyun Kim
SSSamuel Swinford
Samuel Swinford
SLSeong-won Lee
Seong-won Lee
Aging is a risk factor for neurodegenerative disorders, but the molecular link between neuronal aging and neurodegeneration remains unclear. Huntington’s disease (HD) is an inherited neurodegenerative disorder with adult-onset clinical symptoms. Striatal medium spiny neurons (MSNs) are mainly affected in HD, but how aging contributes to MSN degeneration remains uncertain. Using directly converted MSNs from fibroblasts of HD patients (HD-MSNs), we studied age-related pathological features, including neuronal cell death, mutant huntingtin (mHTT) aggregation, and DNA damage in HD. In this study, through transcriptomic analysis of longitudinally aged MSNs and HD-MSNs, we identified four upstream regulators, NFKB1, SOD1, IRF3, and REST, that modulate downstream gene expression in aged MSNs. Among these, knocking down NFKB1 significantly reduced HD pathologies in HD-MSNs, while overexpressing NFKB1 reversed these protective effects. Overall, these results identify NFKB1 as a key age-associated upstream regulator whose downregulation confers neuronal resilience and is a potential therapeutic target in HD.

9 May 2023 in Research Square
Verified
Preprint
Open access
PDF file
AYAndrew Yoo
Andrew Yoo
SLSeong-won Lee
Seong-won Lee
YOYoung Mi Oh
Young Mi Oh
MVMatheus Victor
Matheus Victor
ISIlya Strunilin
Ilya Strunilin
DPDavid Perlmutter
David Perlmutter
Aging is a common risk factor in neurodegenerative disorders and the ability to investigate aging of neurons in an isogenic background would facilitate discovering the interplay between neuronal aging and onset of neurodegeneration. Here, we perform direct neuronal reprogramming of longitudinally collected human fibroblasts to reveal genetic pathways altered at different ages. Comparative transcriptome analysis of longitudinally aged striatal medium spiny neurons (MSNs), a primary neuronal subtype affected in Huntington’s disease (HD), identified pathways associated with RCAN1, a negative regulator of calcineurin. Notably, RCAN1 undergoes age-dependent increase at the protein level detected in reprogrammed MSNs as well as in human postmortem striatum. In patient-derived MSNs of adult-onset HD (HD-MSNs), counteracting RCAN1 by gene knockdown (KD) rescued HD-MSNs from degeneration. The protective effect of RCAN1 KD was associated with enhanced chromatin accessibility of genes involved in longevity and autophagy, mediated through enhanced calcineurin activity, which in turn dephosphorylates and promotes nuclear localization of TFEB transcription factor. Furthermore, we reveal that G2-115 compound, an analog of glibenclamide with autophagy-enhancing activities, reduces the RCAN1-Calcineurin interaction, phenocopying the effect of RCAN1 KD. Our results demonstrate that RCAN1 is a potential genetic or pharmacological target whose reduction-of-function increases neuronal resilience to neurodegeneration in HD through chromatin reconfiguration.